NasdaqCM - Delayed Quote
USD
Chemomab Therapeutics Ltd. (CMMB)
1.1800
+0.0200
(+1.72%)
At close: November 2 at 4:00:01 PM EST
Analyst Insights
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
8/27/2025
Analyst
Oppenheimer
Rating Action
Maintains
Rating
Outperform
Price Action
Raises
Price Target
10 -> 25
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 8/27/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/16/2025 |
| Maintains | Maxim Group: Buy to Buy | 2/20/2025 |
| Reiterates | Oppenheimer: Outperform to Outperform | 11/15/2024 |
| Initiated | Maxim Group: Buy | 5/13/2024 |
| Upgrade | Oppenheimer: Perform to Outperform | 5/6/2024 |
